Belen Ojeda

机构：Centro de Investigaciones Biológicas Margarita Salas

发表论文 91 篇 · 总被引 4010 次 · h-index 28

代表论文

• Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort (2010 · The Lancet · 被引 1275)
• Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort (2014 · The Lancet Oncology · 被引 504)
• Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas (2012 · British Journal of Cancer · 被引 233)
• Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer (2012 · Journal of Clinical Oncology · 被引 164)
• Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study (2005 · Annals of Oncology · 被引 120)
• Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel (2010 · JNCI Journal of the National Cancer Institute · 被引 91)